DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 2NanoAlvand
03 2Lee Fine Chem
04 3Accord healthcare
05 2Accure Labs
06 3Apotex Inc
07 2Azurity Pharma
08 7Bluepharma
09 3CLONMEL HLTHCARE
10 3Cipla
11 1Health Biotech
12 5Hetero Drugs
13 3Intas Pharmaceuticals
14 2Jodas Expoim Pvt. Ltd
15 2MSN Laboratories
16 1Naprod Life Sciences
17 7Novartis Pharmaceuticals Australia Pty Limited
18 8Novartis Pharmaceuticals Corporation
19 2Novartis South Africa (Pty) Ltd
20 3PharOS Ltd
21 3Pinnacle Life Science
22 2Pluviaendo
23 6STADA Arzneimittel
24 2Sichuan Xieli Pharmaceutical
25 5Teva Pharmaceutical Industries
26 2TherDose Pharma
27 4Torrent Pharmaceuticals Limited
28 2Viatris
29 2Zentiva
01 4CAP
02 9CAPSULE
03 11CAPSULE;ORAL
04 21Capsule
05 6Capsules
06 27Hard Capsule
07 2Hard Gelatin Capsule
08 3Oral Solid Dosage Form
09 2TABLET;ORAL
10 7Blank
01 9Approved
02 10Authorised
03 14Authorized
04 8Generic
05 3Lead Market Dossiers- Under Development
06 2Originator
07 11RX
08 35Blank
01 2Assignment
02 2DANZITEN
03 2Lotigna
04 4NILOTINIB
05 3NILOTINIB D-TARTRATE
06 3NILOTINIB HYDROCHLORIDE
07 3NILOTINIB HYDROCHLORIDE DIHYDRATE
08 5Nilotinib
09 3Nilotinib Accord
10 3Nilotinib Clonmel
11 3Nilotinib Pharos
12 6Nilotinib Stada
13 5Nilotinib Teva
14 2Nilotinib Torrent
15 2Nilotinib Viatris
16 4Sunitinib Bluepharma Industry
17 3TASIGNA
18 1Tasicap 150
19 1Tasicap 200
20 10Tasigna
21 1Tasigna 150 Mg
22 1Tasigna 200 Mg
23 23Blank
01 7Australia
02 2China
03 2Czech Republic
04 19India
05 2Iran
06 10Malta
07 3Portugal
08 4South Africa
09 14Spain
10 9Sweden
11 2Turkey
12 18USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Lotigna
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Nilotinib
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Lotigna
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Nilotinib
Dosage Form : Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NILOTINIB HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-01-05
Application Number : 203640
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
NILOTINIB HYDROCHLORIDE DIHYDRATE
Brand Name : NILOTINIB HYDROCHLORIDE DIHYDRATE
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 209651
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 218544
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 218544
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2007-10-29
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2010-06-17
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TASIGNA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2018-03-22
Application Number : 22068
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 218532
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NILOTINIB
Dosage Form : CAPSULE
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 218532
Regulatory Info :
Registration Country : USA
